TRAVERE THERAPEUTICS INC (TVTX:NASDAQ)
$55.51 -1.17 (-2.0642%)
Analysed TRAVERE THERAPEUTICS INC (TVTX:NASDAQ) News Sources
Everest Medicines Enters into Exclusive Licensing Agreement with Travere Therapeutics for Civorebrutinib a Potential Best-in-Class BTK Inhibitor for Rare Kidney Diseases
02-06-2026
yahoo.com
TVTX Stock Slides 6% On Everest Deal, Erases Some Losses As Analyst Sees 49% Upside
02-06-2026
stocktwits.com
3 Stocks That May Be Priced Below Their Estimated Worth In June 2026
03-06-2026
yahoo.com
Extreme Networks And 2 Other Stocks That Could Be Trading Below Their Estimated Value
03-06-2026
yahoo.com
Travere Therapeutics Presents Long-Term Open-Label Extension Data from the Phase 3 DUPLEX Study at the 63rd European Renal Association (ERA) 2026 Congress
04-06-2026
yahoo.com
3 Stocks That May Be Priced Below Their Estimated Value In June 2026
08-06-2026
yahoo.com
Is Travere Therapeutics, Inc. (TVTX) A Good Stock To Buy Now?
13-06-2026
yahoo.com
Travere Therapeutics Announces Planned Retirement of Chief Research Officer in 2027
16-06-2026
yahoo.com
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
10-07-2026
yahoo.com
This Stock Of The Day Rides Big Pharma Royalties; It's Up 56% In 2026
27-07-2026
yahoo.com
What is the current price of TRAVERE THERAPEUTICS INC (TVTX:NASDAQ)?
The current price of TRAVERE THERAPEUTICS INC (TVTX:NASDAQ) is $55.51.
TRAVERE THERAPEUTICS INC (TVTX:NASDAQ) absolute price change since previous trading day?
The absolute price change of TRAVERE THERAPEUTICS INC (TVTX:NASDAQ) since the previous trading day is $-1.17.
TRAVERE THERAPEUTICS INC (TVTX:NASDAQ) percentage price change since previous trading day?
The percentage price change of TRAVERE THERAPEUTICS INC (TVTX:NASDAQ) since the previous trading day is -2.0642%.
What is the most recent average sentiment score for TRAVERE THERAPEUTICS INC (TVTX:NASDAQ)?
The most recent average sentiment score for TRAVERE THERAPEUTICS INC (TVTX:NASDAQ) is 81 out of 100.
What is the most recent average sentiment for TRAVERE THERAPEUTICS INC (TVTX:NASDAQ)?
The most recent sentiment for TRAVERE THERAPEUTICS INC (TVTX:NASDAQ) is .
SEC-8K** Filing Available For TRAVERE THERAPEUTICS INC (TVTX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.